questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité immédiate
Hypersensibilité respiratoire
Aspergillose bronchopulmonaire allergique
Aspergillose bronchopulmonaire allergique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Molecular Docking Simulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aspergillose bronchopulmonaire allergique : Questions médicales les plus fréquentes",
"headline": "Aspergillose bronchopulmonaire allergique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aspergillose bronchopulmonaire allergique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-21",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aspergillose bronchopulmonaire allergique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité respiratoire",
"url": "https://questionsmedicales.fr/mesh/D012130",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité respiratoire",
"code": {
"@type": "MedicalCode",
"code": "D012130",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.480.680"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Aspergillose bronchopulmonaire allergique",
"alternateName": "Aspergillosis, Allergic Bronchopulmonary",
"code": {
"@type": "MedicalCode",
"code": "D001229",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ritesh Agarwal",
"url": "https://questionsmedicales.fr/author/Ritesh%20Agarwal",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India. Electronic address: agarwal.ritesh@outlook.in."
}
},
{
"@type": "Person",
"name": "Valliappan Muthu",
"url": "https://questionsmedicales.fr/author/Valliappan%20Muthu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India."
}
},
{
"@type": "Person",
"name": "Sahajal Dhooria",
"url": "https://questionsmedicales.fr/author/Sahajal%20Dhooria",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India."
}
},
{
"@type": "Person",
"name": "Arunaloke Chakrabarti",
"url": "https://questionsmedicales.fr/author/Arunaloke%20Chakrabarti",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India."
}
},
{
"@type": "Person",
"name": "Inderpaul Singh Sehgal",
"url": "https://questionsmedicales.fr/author/Inderpaul%20Singh%20Sehgal",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.",
"datePublished": "2022-08-26",
"url": "https://questionsmedicales.fr/article/36026508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0268269"
}
},
{
"@type": "ScholarlyArticle",
"name": "Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38773273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-62520-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation.",
"datePublished": "2024-09-06",
"url": "https://questionsmedicales.fr/article/39243097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41065-024-00334-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/38981921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00894-024-06060-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37453331",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2023.136836"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité immédiate",
"item": "https://questionsmedicales.fr/mesh/D006969"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypersensibilité respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012130"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aspergillose bronchopulmonaire allergique",
"item": "https://questionsmedicales.fr/mesh/D001229"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aspergillose bronchopulmonaire allergique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aspergillose bronchopulmonaire allergique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aspergillose bronchopulmonaire allergique",
"description": "Comment diagnostiquer l'aspergillose bronchopulmonaire allergique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes sont-ils suffisants pour le diagnostic ?\nQuel rôle joue la culture de mucus dans le diagnostic ?\nLes antécédents médicaux sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=Molecular+Docking+Simulation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aspergillose bronchopulmonaire allergique",
"description": "Quels sont les symptômes courants de cette maladie ?\nLa fièvre est-elle un symptôme fréquent ?\nY a-t-il des symptômes spécifiques chez les asthmatiques ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?\nPeut-on avoir des symptômes sans infection active ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=Molecular+Docking+Simulation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aspergillose bronchopulmonaire allergique",
"description": "Comment prévenir l'aspergillose bronchopulmonaire allergique ?\nLes personnes allergiques doivent-elles prendre des précautions ?\nLe port de masques est-il recommandé ?\nL'humidité intérieure joue-t-elle un rôle ?\nLes traitements préventifs sont-ils disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=Molecular+Docking+Simulation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aspergillose bronchopulmonaire allergique",
"description": "Quels traitements sont disponibles pour cette condition ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des antifongiques ?\nLes bronchodilatateurs sont-ils nécessaires ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=Molecular+Docking+Simulation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aspergillose bronchopulmonaire allergique",
"description": "Quelles complications peuvent survenir ?\nLes bronchiectasies sont-elles une complication fréquente ?\nL'insuffisance respiratoire est-elle possible ?\nLes complications peuvent-elles être évitées ?\nY a-t-il un risque de mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=Molecular+Docking+Simulation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aspergillose bronchopulmonaire allergique",
"description": "Quels sont les principaux facteurs de risque ?\nLa fibrose kystique augmente-t-elle le risque ?\nLes personnes âgées sont-elles plus à risque ?\nL'exposition professionnelle joue-t-elle un rôle ?\nLes antécédents d'allergies augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=Molecular+Docking+Simulation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'aspergillose bronchopulmonaire allergique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, les tests d'allergie et les examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent des tests cutanés, des dosages d'IgE spécifiques et des radiographies thoraciques."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils suffisants pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être corroborés par des tests spécifiques pour un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la culture de mucus dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture de mucus peut aider à identifier la présence d'Aspergillus dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux sont-ils importants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'allergies ou d'asthme sont cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de cette maladie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, fièvre et production de mucus coloré."
}
},
{
"@type": "Question",
"name": "La fièvre est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre peut survenir, surtout lors d'une exacerbation des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les asthmatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les asthmatiques peuvent éprouver une aggravation de l'asthme et des crises plus fréquentes."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans infection active ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes allergiques peuvent survenir sans infection fongique active."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'aspergillose bronchopulmonaire allergique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition aux spores d'Aspergillus et maintenir un environnement propre."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les zones à forte concentration de spores, comme les chantiers de construction."
}
},
{
"@type": "Question",
"name": "Le port de masques est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut réduire l'exposition aux spores dans des environnements à risque."
}
},
{
"@type": "Question",
"name": "L'humidité intérieure joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un faible taux d'humidité peut aider à réduire la prolifération des spores."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils disponibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs peuvent être envisagés pour les patients à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour cette condition ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des corticostéroïdes, des antifongiques et des bronchodilatateurs."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et améliorent les symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on des antifongiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques sont utilisés en cas d'infection fongique confirmée ou sévère."
}
},
{
"@type": "Question",
"name": "Les bronchodilatateurs sont-ils nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à soulager l'essoufflement et à améliorer la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'immunothérapie peuvent être envisagés dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections pulmonaires, des bronchiectasies et une insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "Les bronchiectasies sont-elles une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent se développer en raison de l'inflammation chronique des voies respiratoires."
}
},
{
"@type": "Question",
"name": "L'insuffisance respiratoire est-elle possible ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une insuffisance respiratoire peut survenir dans les cas graves ou non traités."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion précoce et appropriée des symptômes peut aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de mortalité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, le risque de mortalité peut augmenter, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'asthme, la fibrose kystique et l'immunodépression."
}
},
{
"@type": "Question",
"name": "La fibrose kystique augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de fibrose kystique sont plus susceptibles de développer cette maladie."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut augmenter la susceptibilité aux infections fongiques."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs exposés à des spores d'Aspergillus, comme les agriculteurs, sont à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies respiratoires sont plus vulnérables."
}
}
]
}
]
}
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires ...
Leishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting millions of people, mainly in tropical countries, due to poor social conditions and low economic development. First-...
Previous clinical and basic studies have revealed that ginseng might have cardioprotective properties against anthracycline-induced cardiotoxicity (AIC). However, the underlying mechanism of ginseng a...
Fourteen drug-disease common targets were identified. Enrichment analysis showed that the AGE-RAGE in diabetic complications, fluid shear stress and atherosclerosis, and TNF signaling pathway were pot...
This study suggested that ginseng might exert their protective effects against AIC through the derived effector compounds beta-Sitosterol, Kaempferol and Fumarine by targeting CCNA2, STAT1, and ICAM1,...
Diabetes mellitus (DM) is a metabolic disorder disease that causes hyperglycemia conditions and associated with various chronic complications leading to mortality. Due to high toxicity of conventional...
Docking between ligand and FOXO1 receptor was carried out with Autodock4.2. For molecular dynamics simulations, the force fields of DNA.OL15, protein.ff14SB, gaff2, and tip3p were used....
During storage and processing, muscle proteins, e.g. myosin and myoglobin, will inevitably undergo degeneration, which is thus accompanied by quality deterioration of muscle foods. Some exogenous addi...
Cereblon (CRBN) is a substrate receptor of E3 ubiquitin ligase as well as the target of thalidomide and lenalidomide, plays a vital role in endogenous protein degradation. In this article, two series ...
Direct oral anticoagulants are an important and relatively new class of synthetic anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic disorders. However, they still have some l...
Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this study, HQSAR, CoMFA, CoMSIA and TopomerCoMFA m...
The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vac...
Oritavancin is a semi-synthetic lipoglycopeptide antibiotic primarily used to treat serious infections caused by Gram-positive bacteria. The aim of this study was to elucidate possible molecular targe...
Computational methods were used in this study which include target prediction, molecular docking, molecular dynamics simulation, pharmacokinetics prediction, and physiological-based pharmacokinetics (...
Oritavancin was moderately soluble in water and did not permeate the blood-brain barrier. Seven molecular targets were identified in humans. Molecular docking results showed highest binding affinity o...
This comprehensive computational study has provided invaluable insights into the pharmacological profile of Oritavancin, aiding its further development and optimization for clinical use....